The role of EGFR mutations in predicting recurrence in early and locally advanced lung adenocarcinoma following definitive therapy

Introduction: Roughly one third of new non-small cell lung cancer (NSCLC) is diagnosed at early stages. While lobectomy can improve mortality in this group, about 30–55% of patients will experience disease recurrence. Increased investigation into the factors affecting recurrence, particularly tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Galvez, Carlos, Jacob, Saya, Finkelman, Brian S., Zhao, Jeffrey, Tegtmeyer, Kyle, Chae, Young Kwang, Mohindra, Nisha, Salgia, Ravi, Jovanovic, Borko, Behdad, Amir, Villaflor, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260116/
https://www.ncbi.nlm.nih.gov/pubmed/32523650
http://dx.doi.org/10.18632/oncotarget.27602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260116/
https://www.ncbi.nlm.nih.gov/pubmed/32523650
http://dx.doi.org/10.18632/oncotarget.27602

Ejemplares similares